Trial Profile
A trial to study the effect of colistin versus ceftazidime/avibactam in the treatment of carbapenem-resistant Klebsiella pneumoniae infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2016
Price :
$35
*
At a glance
- Drugs Avibactam/ceftazidime (Primary) ; Colistin (Primary)
- Indications Klebsiella infections
- Focus Therapeutic Use
- Acronyms CRACKLE
- 10 May 2016 New trial record
- 12 Apr 2016 Results presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases